![](https://images.squarespace-cdn.com/content/v1/65aa65b95113f749d9ac5091/9268e2ad-3ca4-4935-9c7b-1e9768d0ed08/Squiggle-asset-large.png)
We make genomics happen.
Improving health by putting genomic innovation into practice.
We enable partners to translate and implement genomic and digital health technologies into clinical practice, accelerating the potential of precision medicine at scale.
We have 30+ years of expertise in pharmacogenetics. That’s the science that links our genetics to the way we respond to common medicines.
Today, prescriptions are made on a trial-and-error basis as standard, meaning people often receive medicines that don’t work for them, or even cause harmful side effects. We are on a mission to change that.
HI THERE. WE’RE FAVA HEALTH.
We are experts in
Genomics
Digital health
Implementation
How we can help
For health systems
Implementing genomics improves care and outcomes, whilst reducing long-term costs
The main challenge facing genomics is clinical implementation. The pace of innovation has overtaken the capacity of health systems to adapt and accept new scientific discoveries.
We build design-led digital genomic services that are tailored to local contexts aimed at system-wide adoption and population-level impact.
For life sciences
Accelerating the translation of genomic and digital technologies into commercial products
Accessing deep clinical and scientific expertise to guide innovation can be tough. Identifying impactful projects and maximising the likelihood of return is a priority for the life science sector.
We offer bespoke support bringing together expertise across domains to create value for our clients.
For individuals
Improving the safety and effectiveness of medicines through easy at-home genetic testing (beta)
Medicines work well for some people, not at all for a few, and for others can even have harmful side effects. A lot of that is determined by our genes.
We provide access to easy at-home genetic testing in partnership with healthcare providers that will show you how you respond to commonly prescribed medications, improving the likelihood they work for you.
Our Team
-
Bill Newman
MD, PhD, Chief Scientific Officer
Bill is a consultant clinical geneticist and professor of genomic medicine. Over the past twenty years, he has held a number of national and international leadership roles shaping genomics. He led the first large scale trial of a pharmacogenetic test in the NHS and is committed to widespread adoption of precision medicine for patient benefit.
-
Videha Sharma
MD, PhD, Chief Executive Officer
Videha is a doctor and innovator specialising in digital health and precision medicine. He has a PhD in Health Informatics and completed fellowships in digital health, medical leadership and clinical entrepreneurship. Videha loves to work across different disciplines and push the boundaries of healthcare innovation to improve patient outcomes.
-
John McDermott
MD, Chief Medical Officer
John is a geneticist specialising in the use of pharmacogenetics in routine practice. He has deep expertise in genomic testing technologies and has led several clinical trials related to personalised medicine. John is an advocate for patient choice and regularly engages communities to ensure Fava design solutions are inclusive and accessible.
-
Eliska Collier
MA (Cantab), Chief Strategy Officer
Eliska is a brand strategist, UX and brand designer, and a qualified corporate (private equity) lawyer by background. She is a creative problem solver and brings design, commercial and legal expertise to the team. Eliska heads up Fava’s business and marketing strategy.